EXOPULSE
LIVE

Serial Number

79402456

Owner

EXO Biologics, Société anonyme

Attorney

Clifford D. Hyra

Filing Date

May 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EXOPULSE Trademark

Serial Number: 79402456

EXOPULSE is a trademark filed by EXO Biologics, Société anonyme on May 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

EXO Biologics, Société anonyme (2 trademarks)

Boulevard de Patience et Beaujonc 3 bte 2

Entity Type: 33

Trademark Details

Filing Date

May 13, 2024

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Extracellular vesicles, namely, exosomes for medical use; extracellular vesicles for clinical use; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; living cells for medical purposes; pharmaceutical preparations and substances, namely, extracellular vesicles for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; dermatological preparations; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified extracellular vesicles for therapeutic use; pharmaceutical preparations, namely, extracellular vesicles to deliver protein or RNA for genetic therapy; biological preparations for use in cell cultures for medical purposes; biological preparations comprising extracellular vesicles for medical purposes; biological preparations comprising a therapeutic target protein-loaded extracellular vesicles for medical purposes; biological preparations comprising extracellular vesicles for pharmaceutical purposes; biological reagents for medical use; medical preparations for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; none of the aforesaid products being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software

Custom manufacturing of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications for others; custom manufacturing consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software

Contract new product research and contract new product development in the field of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications; biotechnological and medical research and product development; extracellular vesicles research and development for therapies; culturing of cells and tissues for others for scientific research purposes; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services in the field of extracellular vesicles; biological research; clinical research in the field of extracellular vesicles; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; scientific research in the nature of conducting clinical trials for others; scientific consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2026 CNEA
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 24, 2025 CRCV
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 8, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 8, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 8, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2025 TROA
REFUSAL PROCESSED BY IB
Feb 1, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2024 REPR